All News
52% of pediatric rheumatology patients do not make initial appointments or follow ups with adult rheumatology after 2 years of transfer of care! Dr. @hausmannMD #RNL2022 @RheumNow https://t.co/3lVxH1yqud
Dr. Rachel Tate uptoTate ( View Tweet)
Cool apps that helps assessing skin and nail disease activity in Psoriasis.
Joseph Merola @RheumNow #rnl2022 https://t.co/CI1Zkt5Io3
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Dr. J Merola recc patients download the Psorcast app; this tool helps patients with #psoriasis and #PsoriaticArthritis track their disease and support research (on App store, launched 1/2022) https://t.co/KLKv5nz4Bb #RNL2022 @rheumnow @CreakyJoints https://t.co/OMnAFJr4xY
TheDaoIndex KDAO2011 ( View Tweet)
Wow.. #JIA patients evolve into different categories over time. Dr Jon Hausmanns talk at #RNL2022 @hausmannMD https://t.co/fefXB2fFmJ
Dr. John Cush RheumNow ( View Tweet)
Role of combined clinic (derm rheum) in managing PsA.
Best way to help patient in my opinion!!
Joseph Merola @RheumNow #RNL2022 https://t.co/98i3qQ6rxp
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
#ClinicalPearl Patients with #psoriatic arthritis do better if #rheumatologists and #dermatologists work together. Many different models. More apt to get holistic Rx. Rheumatic are u less familiar with topicals for #psoriasis @RheumNow #RNL2022 Dr Joe Merida https://t.co/nVZe7ZwBqI
Janet Pope Janetbirdope ( View Tweet)
Derm please help, Joint improved but skin didn't!!
What to do?
Joseph Merola @RheumNow #rnl2022 https://t.co/DrmtEJZnBx
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Other diagnosis to consider if Skin psoriasis didn't improve.
▶️Consider other skin disease like dermatitis.
▶️Always consult Dermatology.
Joseph Merola @RheumNow #RNL2022 https://t.co/ysPHQs5SCz
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Can we prevent PsA?!
That would be great!, studies are ongoing.
Joseph Merola @RheumNow #rnl2022 https://t.co/3c0duNQWGu
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
"Quality of life of the patient is maximized when we treat both skin and joints." Dr. Merola quoting Dr. Kavanaugh at #RNL2022 I would add treatment for any active domains improves QoL for our Psoriatic disease patients. @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Dr Joseph Merola presenting on collaborative Rheum-derm clinics for the care of psoriatic disease. https://t.co/K37HZazbtr has resources to facilitate. #RNL2022 https://t.co/9l3n5xzyjF
Links:
Dr. John Cush RheumNow ( View Tweet)
Pod 6 starts at 10am ET on Hot Topics in Rheumatology starting with a presentation on Adults with Juvenile Idiopathic Arthritis (It ain’t all child’s play) led by Jonathan Hausmann, MD. #RNL2022 https://t.co/XuURk8gefY
Dr. John Cush RheumNow ( View Tweet)
Run down on IL-17 inhibitors by Dr Strober @BruceStrober #RNL2022 https://t.co/mqXvfJGhij
Dr. John Cush RheumNow ( View Tweet)
What's unique about the new Tyk2 inhibitor, deucravacitinib, under study in #PSO and #PsA. #RNL2022 https://t.co/J04uJxeX2v
Dr. John Cush RheumNow ( View Tweet)
Dr Bruce Strober reviews new classification scheme for psoriasis patients who are candidates for typical or systemic therapy. #RNL2022 https://t.co/bWVoIs3Vgn
Dr. John Cush RheumNow ( View Tweet)
Axial PsA Prevalence, Varies with disease duration!!
5 years duration 28%.
25 years duration 70%
Philip Mease @rheumnow #Rnl2022 https://t.co/w5aGiYJ6I0
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Bacteria it self or its metabolites!!
Bacteria ▶️ Short chain fatty acid▶️ T reg Cells ▶️ prevent Autoimmunity!! VERY COOL🤓
Jose Scher @RheumNow #Rnl2022 https://t.co/fJeguIFPmA
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Dysbiosis, interesting word🤓!!
▶️It is a reduction in microbial diversity ▶️ Autoimmunity!!
Jose Scher @RheumNow #Rnl2022 https://t.co/oIYl4RJPSy
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Role of IL17 blockers in creating dysbiosis (expansion of Candida), could that be one of the reasons explaining its effect in SpA and PsA?!!
Jose Scher @RheumNow #Rnl2022 https://t.co/AyGgNiDVJ9
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Less diversity ▶️ worse disease activity in Axial SpA!!
Jose Scher @RheumNow #Rnl2022 https://t.co/HwwceaKW6M
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)